tiprankstipranks
Global Blood Therapeutics (GBT)
NASDAQ:GBT
Holding GBT?
Track your performance easily

Global Blood Therapeutics (GBT) Income Statement

0 Followers

Global Blood Therapeutics Income Statement

Last quarter (Q ), Global Blood Therapeutics's total revenue was $71.55M, an increase of 50.46% from the same quarter last year. In Q, Global Blood Therapeutics's net income was $-82.47M. See Global Blood Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 21Dec 20Dec 19Dec 18Dec 17
Total Revenue
$ 234.86M$ 194.75M$ 123.80M$ 2.11M$ 0.00$ 0.00
Cost of Revenue
$ 4.45M$ 3.32M$ 1.99M$ 48.00K$ 0.00$ 0.00
Gross Profit
$ 230.41M$ 191.43M$ 121.82M$ 2.06M$ 0.00$ 0.00
Operating Expense
$ 529.65M$ 479.12M$ 365.97M$ 291.64M$ 182.74M$ 119.25M
Operating Income
$ -299.24M$ -287.69M$ -244.16M$ -289.58M$ -182.74M$ -119.25M
Net Non Operating Interest Income Expense
$ -22.32M$ -14.75M$ -3.98M$ 14.70M$ 8.62M$ 2.56M
Other Income Expense
$ -62.00K$ -177.00K$ 578.00K$ 8.12M$ -69.00K$ -334.00K
Pretax Income
$ -321.62M$ -302.61M$ -247.55M$ -266.77M$ -174.19M$ -117.02M
Tax Provision
$ 363.00K$ 477.00K$ 0.00---
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -322.46M$ -303.09M$ -247.55M$ -266.77M$ -174.19M$ -117.02M
Basic EPS
$ -5.01$ -4.81$ -4.04$ -4.57$ -3.41$ -2.76
Diluted EPS
$ -5.01$ -4.81$ -4.04$ -4.57$ -3.41$ -2.76
Basic Average Shares
$ 257.87M$ 62.96M$ 61.33M$ 58.32M$ 51.15M$ 42.32M
Diluted Average Shares
$ 257.87M$ 62.96M$ 61.33M$ 58.32M$ 51.15M$ 42.32M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 534.10M$ 482.44M$ 367.96M$ 291.69M$ 182.74M$ 119.25M
Net Income From Continuing And Discontinued Operation
$ -322.46M$ -303.09M$ -247.55M$ -266.77M$ -174.19M$ -117.02M
Normalized Income
$ -322.46M$ -303.09M$ -248.54M$ -275.07M$ -174.19M$ -117.02M
Interest Expense
$ 24.71M$ 15.47M$ 9.81M$ 894.00K$ 346.00K-
EBIT
$ -296.91M$ -287.15M$ -237.74M$ -265.87M$ -173.85M$ -119.25M
EBITDA
$ -287.94M$ -278.53M$ -226.92M$ -255.94M$ -169.24M$ -117.59M
Currency in USD

Global Blood Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis